@FierceBiotech: The top 10 biopharma pipeline disasters of 2015. Feature | Follow @FierceBiotech
@JohnCFierce: ICYMI: AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients. Story | Follow @JohnCFierce
@DamianFierce: Solid use of the double question mark in the otherwise disappointing Citron $VRX screed. More | Follow @DamianFierce
> Despite headwinds related to drug pricing, influential U.K. investor Woodford Funds remains bullish on U.S. biopharma. More
> Controversial entrepreneur Patrick Soon-Shiong has emerged as an ally to Vice President Joe Biden, who has shifted his attention to the fight against cancer. News
> Despite the recent struggles of biotechs trying to go public, Atlas Venture's Michael Gladstone argues it's still a good time to be investing in early-stage drug development companies. Blog
Medical Device News
@FierceMedDev: 450+ hospitals pay DOJ $250M for overuse of ICDs at the expense of Medicare. Report | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Flowonix to develop drug delivery implant for Cerebral's neurological candidates. Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI Friday: Quest Medical launches recall for open heart surgery drug delivery devices. Article | Follow @EmilyWFierce
> Conventus bags $21M in equity to commercialize minimally invasive implants to treat fractures. More
> Researchers develop topical device that measures skin health, blood flow. Story
Pharma News
@FiercePharma: Novartis sees doc-education push, DTC as crucial to amping up Entresto launch. FiercePharmaMarketing story | Follow @FiercePharma
@EricPFierce: ICYMI: Pfizer and GlaxoSmithKline are collaborating on continuous manufacturing. FiercePharmaManufacturing item | Follow @EricPFierce
@CarlyHFierce: Shire locks down rivals to its rare-disease franchise with $5.9B Dyax buy. News | Follow @CarlyHFierce
> It's open season for Mylan's EpiPen as Sanofi, Teva stumble. Item
> FDA finds fault with Pfizer China plant. Story
> JAMA: 'Groundbreaking,' 'miracle' drugs not all they're cracked up to be in news stories. More
Animal Health News
> Investors cheer Abaxis but trounce IDEXX on quarterly diagnostics performance. More
> NexGard demand drives strong Q3 growth for Sanofi's Merial. Item
> Tufts vet borrows techniques from human medicine to repair facial fractures in dogs. Story
> Colorado State University scientists use fertility know-how to revive Yellowstone bison. Report
> VCA beats on earnings but misses the mark on revenue in Q3. Article
Biotech IT News
> Ex-BGI CEO sets up AI-enabled health data mining operation. Report
> Genomics boom puts strain on data storage, electricity grid. Story
> Alibaba, BGI and Intel team up for precision medicine project. Article
> Chinese sequencing sector heats up as BGI, Direct Genomics prepare products. Item
> FDA seeks industry feedback on virtual and BYOD clinical trials. More
Pharma Marketing News
> Shire dodges HAE competition with $5.9B Dyax buyout. Item
> Sanofi's Auvi-Q recall puts Mylan's rival EpiPen in full control of blockbuster market. Report
> Novartis sees doc-education push, DTC as crucial to amping up Entresto launch. Story
> Feds arrest, charge ex-Warner Chilcott sales execs in kickbacks case. More
> GSK readies respiratory sales force to challenge Xolair in severe asthma. Article